Novavax Inc (WBO:NVAX)
€ 9.276 -0.09 (-0.96%) Market Cap: 1.49 Bil Enterprise Value: 734.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 47/100

Novavax Inc at Cowen Health Care Conference (Virtual) Transcript

Mar 08, 2022 / 02:50PM GMT
Georgi Nenov Yordanov
Cowen and Company, LLC, Research Division - Specialty Pharma Associate

All right. Welcome, everyone. I'm really excited to have Novavax Management, specifically John Trizzino, Chief Operating Officer (sic) [Chief Commercial Officer] and Chief Business Officer; as well as Filip Dubovsky, who is the Chief Medical Officer of Novavax.

Questions & Answers

Georgi Nenov Yordanov
Cowen and Company, LLC, Research Division - Specialty Pharma Associate

So obviously, you guys just had your quarterly call last week, issued your 2022 guidance of $4 billion to $5 billion. So maybe we can just get right into it and then maybe you can just walk us through the different components that make up this guidance, and then we can take it from there.

John Joseph Trizzino
Novavax, Inc. - Executive VP and Chief Business & Commercial Officer

Yes. Sure. Georgi, first of all, thanks for having us. I think it was an exciting earnings call. It's chock-full of -- a lot of information about where the company is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot